A service of arranging or bringing about contact between an investment manager and an issuer or potential issuer.
ENGLEWOOD, Colo., Oct. 18, 2017 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty life sciences company focused on global commercialization of novel products in the field of urology, today announced that its shares of common stock were approved for listing on The...
Company invites individual and institutional investors as well as advisors to log-on to VirtualInvestorConferences.com to view presentation ENGLEWOOD, Colo., Oct. 9, 2017 -- Aytu BioScience (OTCQX: AYTU), a specialty life sciences company focused on global...
ENGLEWOOD, Colo., Oct. 3, 2017 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty life sciences company focused on global commercialization of novel products in the field of urology, today announced that the company has entered into a distribution agreement with...
Company invites individual and institutional investors as well as advisors to attend interactive real-time virtual VirtualInvestorConferences.com ENGLEWOOD, Colo., Sept. 28, 2017 -- Aytu BioScience (OTCQX: AYTU), a specialty life sciences company focused on global...
Temporary Ticker Symbol 'AYTUD' is No Longer Active as of September 28, 2017ENGLEWOOD, Colo., Sept. 28, 2017 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty life sciences company focused on global commercialization of novel products in the field of urology, today...
ENGLEWOOD, Colo., Aug. 29, 2017 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty life sciences company focused on global commercialization of novel products in the field of urology, today announced that a previously announced 1-for-20 reverse split of its...
ENGLEWOOD, Colo., Aug. 25, 2017 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty life sciences company focused on global commercialization of novel products in the field of urology, today announced that a previously approved 1-for-20 reverse split of its...
Live Conference Call and Webcast Scheduled for August 31, 2017, at 10:30 a.m. ETENGLEWOOD, Colo., Aug. 24, 2017 -- Aytu BioScience, Inc. (OTCQX: AYTU), a specialty life sciences company focused on global commercialization of novel products in the field of urology,...
ENGLEWOOD, Colo., Aug. 15, 2017 -- Aytu BioScience, Inc. (OTCQX: AYTU) a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, today announced the closing, on August 15, 2017, of its previously disclosed...
ENGLEWOOD, Colo., Aug. 11, 2017 -- Aytu BioScience, Inc. (OTCQX: AYTU) a specialty pharmaceutical company focused on global commercialization of novel products in the field of urology, today announced that it has received subscriptions for a private placement in the...